PR Newswire MISSION, Kan., Nov. 4, 2024 Take steps to limit risk for cardiovascular disease MISSION, Kan., Nov. 4, 2024 /PRNewswire/ -- (Family Features) The last decade has seen a surge in cardiovascular risk factors such as ...
PR Newswire LAS VEGAS, Nov. 4, 2024 Transformative, non-invasive technology provides real-time insights into cardiac performance and fluid status, enabling clinicians to optimize heart failure treatment earlier than ever and improve patient ...
PR Newswire WASHINGTON, Oct. 31, 2024 ABC's 'Family Heartbeats Unmasked' inspires awareness and action through the heartfelt stories of families diagnosed with FH. WASHINGTON, Oct. 31, 2024 /PRNewswire/ -- As part of its ongoing ...
PR Newswire NEW PROVIDENCE, N.J., Oct. 29, 2024 NEW PROVIDENCE, N.J., Oct. 29, 2024 /PRNewswire/ -- Evolution Research Group (ERG) and Lotus, portfolio companies of Emerge HoldCo, LLC, in collaboration with their strategic partner Gonzaba ...
PR Newswire CHICAGO, Oct. 28, 2024 CHICAGO, Oct. 28, 2024 /PRNewswire/ -- Cardiosense, a digital health company developing heart failure management platforms for the early detection of worsening heart failure, today presented clinical data ...
PR Newswire DANVERS, Mass., Oct. 28, 2024 DANVERS, Mass., Oct. 28, 2024 /PRNewswire/ -- Results were presented at Transcatheter Cardiovascular Therapeutics (TCT) 2024 conference from the first completed pivotal trial on patients supported ...
PR Newswire CARLSBAD, Calif., Oct. 28, 2024 Bolt Medical announced the intravascular ultrasound (IVUS) results of 22 patients enrolled in the RESTORE FIH (First in Human) Coronary feasibility clinical trial using the company's Bolt IVL™ ...
PR Newswire LOS GATOS, Calif., Oct. 27, 2024 LOS GATOS, Calif., Oct. 27, 2024 /PRNewswire/ -- Adona Medical, a Shifamed portfolio company that aims to deliver advanced solutions for heart failure, announced today the successful ...
PR Newswire TEWKSBURY, Mass., Oct. 25, 2024 44% reduction in total heart failure event rate and ongoing improvements in quality of life in responder group patients implanted with shunt TEWKSBURY, Mass., Oct. 25, 2024 /PRNewswire/ -- ...
PR Newswire ABBOTT PARK, Ill., Oct. 24, 2024 ABBOTT PARK, Ill., Oct. 24, 2024 /PRNewswire/ -- Abbott (NYSE: ABT) today announced a new, first-of-its-kind clinical trial designed to improve outcomes in patients with worsening heart failure ...
Discover how BMAL1–HIF2A interactions control circadian rhythms in heart injury, revealing a potential pathway for time-based cardioprotective therapies.
Medically tailored meals significantly improve heart failure patients’ nutrition and reduce hospital readmissions.
Early ezetimibe initiation after myocardial infarction significantly lowers cardiovascular events compared to delayed or no combination lipid-lowering therapy.
A novel diffusion model generates synthetic atrial fibrosis images to augment data for deep learning, improving prediction of AF ablation outcomes in silico.
Living in low-walkability neighborhoods is linked to a higher risk of cardiovascular disease, new research shows.
Subscribe to our Free Newsletters!
Medindia's policies are aligned with the United Nations Sustainable Development Goals (SDGs) - SDG 3, SDG 4, SDG 5, SDG 6 , SDG 10 & SDG 12.
Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment.
Full Disclaimer
Advertise with us | Medindia Copyright | Privacy Policy | Terms of Use © All Rights Reserved 1997 - 2025
Careers